|
Time
|
Any site, (%)
|
Nasal cavity, (%)
|
Throat, (%)
|
Inguinal area, (%)
|
Rectum, (%)
|
|---|
|
ESBL-producing Enterobacteriaceae
|
|
Time-1 (N = 487)
|
52.2
|
2.7
|
9.8
|
17.5
|
50.4
|
|
Time-2 (N = 357)
|
51.8
|
3.4
|
15.1
|
17.5
|
46.2
|
|
Time-3 (N = 162)
|
62.3
|
8.3
|
25.0
|
21.9
|
46.2
|
|
Time-4 (N = 53)
|
71.7
|
12.0
|
28.6
|
27.1
|
53.8
|
|
ESBL-producing E. coli
| |
|
Time-1 (N = 487)
|
42.3
|
1.0
|
2.9
|
11.9
|
38.8
|
|
Time-2 (N = 357)
|
41.2
|
1.3
|
3.7
|
10.9
|
34.3
|
|
Time-3 (N = 162)
|
39.5
|
0.6
|
3.3
|
10.3
|
33.1
|
|
Time-4 (N = 53)
|
41.5
|
2.0
|
4.1
|
16.7
|
32.7
|
|
ESBL-producing Klebsiella spp.
|
|
Time-1 (N = 487)
|
16.6
|
1.9
|
6.4
|
5.9
|
12.3
|
|
Time-2 (N = 357)
|
19.1
|
2.2
|
10.7
|
5.9
|
10.4
|
|
Time-3 (N = 162)
|
34.6
|
7.1
|
19.7
|
9.7
|
19.4
|
|
Time-4 (N = 53)
|
45.3
|
1.0
|
22.5
|
19.4
|
19.2
|
|
CR-AB
|
|
Time-1 (N = 487)
|
6.8
|
2.1
|
2.3
|
3.7
|
2.5
|
|
Time-2 (N = 357)
|
16.3
|
4.7
|
6.7
|
10.4
|
8.6
|
|
Time-3 (N = 162)
|
27.8
|
8.3
|
13.2
|
15.5
|
10.0
|
|
Time-4 (N = 53)
|
47.2
|
26.0
|
24.5
|
22.9
|
19.2
|
|
CR-PA
|
|
Time-1 (N = 487)
|
4.7
|
1.6
|
3.7
|
0.4
|
1.2
|
|
Time-2 (N = 357)
|
8.4
|
2.2
|
5.4
|
1.8
|
2.1
|
|
Time-3 (N = 162)
|
12.3
|
5.8
|
7.2
|
3.2
|
3.8
|
|
Time-4 (N = 53)
|
18.9
|
10.0
|
12.2
|
2.1
|
1.9
|
|
MRSA
|
|
Time-1 (N = 487)
|
7.2
|
4.3
|
3.5
|
1.2
|
2.5
|
|
Time-2 (N = 357)
|
7.3
|
3.1
|
2.2
|
1.1
|
2.2
|
|
Time-3 (N = 162)
|
11.7
|
4.9
|
2.6
|
3.7
|
1.2
|
|
Time-4 (N = 53)
|
18.9
|
7.5
|
5.7
|
3.7
|
1.8
|
- Abbreviations: ESBL Extended-Spectrum Beta-Lactamase, CR-AB Carbapenem-Resistant Acinetobacter baumannii, CR-PA Carbapenem-Resistant Pseudomonas aeruginosa, MSSA Methicillin-Susceptible Staphylococcus aureus, MRSA Methicillin-Resistant Staphylococcus aureus
